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Effects of Chronic Tobacco Smoking
on the Coronary Circulation
LLOYD W. KLEIN, MD, AUGUSTO D. PICHARD, MD, FACC, JAMES HOLT, MA,
HARRY SMITH, PhD, RICHARD GORLIN, MD, FACC, LOUIS E. TEICHHOLZ, MD, FACC
New York. New York
The effects of chronic smoking on the coronary circu-
lation were studied by evaluating the coronary vascular
reserve in 12 chronic smokers (group 1) and 10 non-
smokers (group 2). All patients were referred to cardiac
catheterization for evaluation of chest pain and were
found to have normal coronary and left ventricular an-
giograms. Coronary vascular reserve was measured by
analyzing the hyperemic response to selective coronary
injection of contrast agent. There was no statistically
significant difference between groups 1and 2 with regard
to age, baseline electrocardiogram or response to tread-
mill or thallium·201 exercise tests.
The mean coronary reserve (± standard deviation)
The immediate physiologic response to cigarette smoking
has been extensively studied in healthy human subjects (1,2)
and includes increases in blood pressure, heart rate and
cardiac output. Increased coronary blood flow has been gen-
erally observed, in both animal (3-7) and human subjects
(8), accompanying the augmentation in cardiac work. In
patients with coronary artery disease (9) and in animal models
with experimental coronary artery narrowing (10-12), cor-
onary blood flow may not change or may actually decrease.
These acute alterations in coronary blood flow produced by
cigarette smoking occur both in response to increased myo-
cardial oxygen demand and through neurally mediated
mechanisms that affect coronary artery dynamics. It is pos-
sible that chronic smoking may produce long-term changes
in coronary artery reactivity.
To assess this hypothesis, we evaluated the coronary
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was 74.1 ± 20.1% in the smokers versus 117.1 ± 45.1%
in the nonsmokers (p < 0.02). In patients who smoked
1 pack a day or less and in those who smoked more than
1 pack a day, the mean coronary reserve was 89.5 and
64.9%, respectively (p < 0.05). Additionally, of 20 pa-
tients followed up for an average of 20 months, 7 of 10
smokers and 1 of 10 nonsmokers continued to have chest
pain (p < 0.03). The cause for the chest pain has not
been established in these patients. These results suggest
that coronary vascular reserve is significantly less in
chronic smokers than in nonsmokers, and that this de-
crease is more pronounced in heavy smokers.
vascular reserve, or capacity of the coronary arteries to dilate
and increase blood flow on increased demand, in chronic
smokers. The coronary reserve alIows for an increase in the
coronary blood flow of at least 200 to 400% to meet the
increased myocardial oxygen requirements associated with
exercise or other stresses (13) . This constitutes an important
physiologic adaptive mechanism, because the myocardial
oxygen extraction is large (± 75%) and nearly maximal
under resting conditions (14, IS) .
Methods
Patient Selection
All patients were referred for diagnosticcardiac catheterization
and coronary angiographyfor a chest pain syndrome. Twenty-two
consecutive patients with normal coronary arteries (as defined by
selective coronary arteriography) and normal left ventricular and
aortic pressures were entered in the study. There were 13 men and
9 women with a mean age of 48 years (range 29 to 65).
Twelve patients who were chronic smokers (group I) were
compared with a control group of 10 nonsmokers (group 2). All
subjects considered chronic smokers had smoked for at least 10
years, and no subjects considered nonsmokers had ever smoked
cigarettes for any length of time. We then further separated the
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smokers into subjects who smoked I pack a day or less (group
IA) and those who smoked more than I pack a day (group IB).
The one cigar smoker could not be classified in either group, and
was deleted from this section of the analysis. These subgroups
were defined by having regularly smoked the specified amount for
at least 5 years before the study. This classification, by number
of packs smoked a day, is somewhat artificial. It is necessary
because of the wide variation among smokers in the volume of
cigarette smoke inhaled and in the nicotine content of the brand
of cigarette smoked. All patients signed informed consent before
cardiac catheterization and agreed to have coronary sinus flow
measurements performed according to a protocol approved by the
Mount Sinai Medical Center Research Administrative Committee.
Procedure and Measurements
Patients were premedicated with 10 mg of oral diazepam and
fasted for at least 10 hours before catheterization. Cigarettes were
withheld for at least I hour before introduction of the coronary
flow studies. Nitrites, beta-receptor blocking agents, calcium an-
tagonists and antiarrhythmic agents were withheld for at least 12
hours before coronary sinus blood flow measurements were made.
Pressures were measured in the aorta and the left ventricle before
and during contrast injection.
Coronary sinus blood flow measurements. Placement of the
coronary sinus catheter was performed after one selective injection
of contrast agent into each coronary artery to confirm that the
coronary arteries were normal. The procedure used for verification
of position in the coronary sinus has been described previously
(16). Coronary sinus blood flow was determined with the contin-
uous thermodilution technique of Ganz et al. (17) using a preshaped
coronary sinus catheter with two thermistors and two pacing elec-
trodes (Wilton Webster Laboratories). Coronary sinus flow at rest
was measured before any further intervention. Hyperemic flow
was defined as the maximal flow recorded after the injection of 6
to 8 cc of contrast medium into the left coronary artery; 3 to 5
injections of contrast medium were given. The largest increase in
coronary flow was chosen for analysis so as to more closely ap-
proximate maximal vasodilation. The average variance in these
values was within the 7 to 10% range as previously described (16).
The percent increase in coronary sinus flow was calculated as
follows: coronary vascular reserve = (Hyperemic flow - Resting
flow)/(Resting flow) x 100. Contrast-induced hyperemia may not
represent maximal coronary flow, as discussed extensively else-
where (16). Data from the coronary sinus flow measurements were
recorded on an Electronics for Medicine recorder at a paper speed
of 2.5 or 5 mm/s. Coronary sinus flow and percent increase in
coronary sinus flow were calculated by computer.
Errors In the measurement of coronary sinus flow may result
if the posterior ventricular vein drains very near the ostium of the
coronary sinus. In such cases, the flow of that vein would not be
included in the measurements obtained. Also, the flow measured
would be artificially decreased if the thermodilution catheter were
positioned too far into the coronary sinus, or artificially increased
if it were too close to the right atrium (18). These considerations
would not influence the conclusions of our study because our
analysis is based on the percent change III flow during hyperemia
recorded at any constant venous drainage site.
Echocardiographic measurements. Echocardiograrns were
obtained within 24 hours of the cathetenzation. All tracings were
of excellent quality. All measurements of left ventricular posterior
wall thickness (LVPW), septum (IVSct) and left ventricular cavity
(LVIDd ) were made according to standard convention (19), and
during diastole before the A wave. Left ventricular (LV) mass was
calculated using the formula (17):
LV mass (g)
0.77 x W [(LVID d + LVPWd + IVSct)3 - (LVIDd)3] + 2.4
Echocardiographic dimensions were measured by an investigator
who had no knowledge of the results of the coronary sinus flow
measurements.
Statistical analysis. The data were maintained and analyzed
using SAS (Statistical Analysis System) on an IBM/370 at the City
University of New York Computing Center. Means and standard
deviations were calculated for all groups by utilizing the maximal
percent increase in coronary sinus flow for each patient.
t-Tests were performed when comparing continuous variables
between two groups. Analysis of variance was performed when
comparing more than two groups. Duncan multiple range tests
were performed at a = 0.05 with the analysis of variance. Pearson
correlation coefficients were calculated when testing relations be-
tween two continuous variables; the chi-square test was performed
when testing two categorical variables.
Results
Table 1 summarizes the pertinent clinical and hemody-
namic data of the 12 chronic smokers (group I) and 10
nonsmokers (group 2). There was no statistically significant
difference between these groups with respect to age (47
versus 47 years), sex (7 of 12 versus 6 of 10 male subjects),
abnormal resting electrocardiogram (7 of 12 versus 3 of 10,
respectively), abnormal exercise treadmill test (5 of 10 ver-
sus 4 of 9), or abnormal exercise thallium tests (3 of 4
versus 5 of 7). All patients had normal calculated left ven-
tricular mass, volumes and pressures. There was no cor-
relation between the coronary vascular reserve and any of
these variables.
The nonsmokers had a significantly higher mean coronary
vascular reserve (117 ± 45. 1%) than the smokers (74. I ±
20.1 %) (p < 0.02) (Fig. 1). When patients in group 1 were
classified into those who smoked 1 pack a day or less
(group l A) and those who smoked more than I pack a day
(group IB), a significant difference in coronary vascular
reserve was revealed between moderate and heavy smokers
(89.5 ± 16.9 versus 64.9 ± 15.1,respectively)(p < 0.05)
(Fig. 2).
Follow-up data. Twenty patients were followed for 3 to
47 months (average 20 months); two in the smokers group
were lost to this follow-up study. All smokers continued to
smoke, and 7 of the 10 continued to have chest pain. Only
I of 10 nonsmokers had persistence of symptoms (p <
0.03). No cause for the chest pain syndrome was found in
these patients despite comprehensive diagnostic evaluation.
CORONARY EFFECTS OF CHRONIC SMOKING
Table 1. Summary of Results in 22 Patients
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Patients (n)
Age (yr)
Sex (male subjects/total)
Resting ECG (abnormalltotal)
Exercise treadmill test (abnormalltotal)
Exercise thallium test (abnormal/total)
Heart rate (beats/min)
LV systolic pressure (mm Hg)
LV mid diastolic pressure (mm Hg)
LV end diastolic pressure (mm Hg)
Aortic diastolic pressure (mm Hg)
LV mass (by echocardiogram) (g)
Coronary smus flow
At rest during hyperemia
Hyperemic flow mmus resting flow*
Coronary vascular reserve (%)*
Persistence of pain (presentltotal)t
Group I
(smokers)
12
46.8 ± 8.5
7 of 12
7 of 12
5 of \0
3 of 4
72.6 ± 9.0
1204 ± 19.2
6.3 ± 4.0
12.6 ± 4.0
71.4 ± 8.2
\17 5 ± 21.9
112.5 ± 52.0
190.7 ± 77.2
78.2 ± 30.2
74.1 ± 20.1
7 of 10
Group 2
(nonsmokers)
10
47.4 ± 9.7
6 of 10
3 of 10
4 of 9
5 of 7
71.3 ± 5.7
\33.3 ± 22.3
10.4 ± 3.4
14.2 ± 4.3
76.7 :! 75
1232 ± 43.\
117.2 ± 67.4
238.1 ± 108.1
120.9 ± 46.2
117.1 ± 45.\
\ of \0
Values represent mean values ± standard devianon except where noted. ECG = electrocardiogram. lV = left ventncular
*p < 0 02. tp < 0 03
Discussion
Hemodynamic effects of smoking. The hemodynamic
response to smoking is the result of a number of effects on
autonomic and peripheral ganglia, systemic hormonal re-
lease and myocardial wall stress and contractility. Cigarette
smoke has been analyzed extensively (20,21); nicotine and
carbon monoxide are the components of most pharmaco-
logic interest with respect to the cardiovascular system (22).
The administration of nicotine intravenously has been shown
to approximate closely the acute hemodynamic effects of
smoking in human beings (23) and in animals (3). The
primary action of nicotine consists of the stimulation of all
sympathetic ganglia (24) resulting in the release of norep-
inephrine from postganglionic adrenergic axon terminals
(25,26). Consequently, vasoconstriction is produced from
direct peripheral ganglion stimulation (27,28), by facilita-
tion of transmission of impulses through ganglia (29), and
from activation of chemoreceptors in the medulla and in the
aortic and carotid bodies (29). As a result, there is a net
increased peripheral resistance, increased heart rate and el-
evated blood pressure. In addition, there is stimulation of
the hypothalamus (25) and the pituitary and adrenal gland
resulting in the systemic release of antidiuretic hormone
(ADH) (30), catecholamines and glucocorticoids (26). The
serum levels of epinephrine and norepinephrine have been
shown (26,31-33) to increase soon after the peripheral cir-
culatory response has started. The catecholamines mediate
increases in heart rate and contractility; thus, although changes
in stroke volume and pulse pressure may vary from indi-
vidual to individual, cardiac output increases principally
because of the increased heart rate (1,2). These effects last
for 10 to 15 minutes after smoking. Long-term hemody-
namic alterations in chronic smokers at rest or with stressful
interventions have not been observed (34).
Effects of smoking on coronary blood flow. An in-
crease in coronary blood flow follows the administration of
cigarette smoke or nicotine in dogs (3-6), heart-lung prep-
arations (6) or rabbits (7), but only when there is a significant
change in cardiac output or blood pressure (3). Bargeron et
al. (8) first investigated changes in coronary blood flow in
normal human subjects utilizing the nitrous oxide desatu-
ration method and found an increase in flow during smoking.
Regan et al. (9,35) studied smoking in patients with and
without coronary artery disease and found that, despite in-
creases in heart rate, cardiac output and blood pressure,
coronary blood flow did not increase in either group. Thus,
smoking increases myocardial work and oxygen demand,
but does not exert a direct action on coronary flow.
Studies of nicotine administration directly into the cor-
onary arteries of dogs have shown similar results (36,37).
Injection of nicotine into the left anterior descending artery
did not alter coronary flow. When positive chronotropic or
inotropic effects, or both, were produced during left cir-
cumflex artery injections, there was invariably an increase
in coronary flow.
Carbon monoxide interferes with oxygen transport, both
by displacing oxygen from the hemoglobin molecule and
by shifting the oxyhemoglobin dissociation curve. By in-
terfering with oxygen release at the tissue level in the myo-
cardium, oxygen demands are further increased, necessi-
tating a compensatory increase in coronary blood flow.
Ayres et al. (38) used carbon monoxide inhalation to raise
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Figure 1. Coronary vascular reserve In 12 subjects who smoked for more
than 10 years and in 10 nonsmokers.
carboxyhemoglobin levels to those developed with smoking.
They found that both cardiac output and coronary blood
flow increased substantially, despite the known negatively
inotropic properties of carbon monoxide (39).
In no human or animal study has coronary vasoconstric-
tion or decreased coronary flow been observed in response
to smoking, nicotine administration or carbon monoxide
inhalation in the absence of coronary artery obstruction. This
is of clinical importance in that there has never been a
documented case of coronary spasm directly attributable to
smoking.
Coronary vascular reserve in chronic smoking. We
found in this study that the coronary vascular reserve is
significantly decreased in chronic smokers as compared with
nonsmokers, and that this decrease is more pronounced in
heavy smokers (Fig. 1 and 2). Our finding that chronic
smoking has a measurable impact on coronary vascular dy-
namics suggests that during maximal metabolic demand,
chronic smokers may be less able than nonsmokers to aug-
ment coronary blood flow, and hence oxygen delivery to
the myocardium. The factor that makes the coronary reserve
correlate significantly with chronic smoking is the change
in the coronary flow with contrast injection-that is, hy-
peremic flow minus resting flow (or ".:l coronary flow").
This difference is significant (p < 0.02) (Table I).
Clinical implications. Although the reduced coronary
reserve is important and intriguing from the physiologic
standpoint, its clinical significance remains to be explored.
What role does it play in explaining the commonly noted
complaints of decreased exercise tolerance and easy fati-
gability of chronic smokers? How does it participate in the
pathogenesis of the chest pain syndrome with normal cor-
onary arteries? The clinical characteristics of the chest pain
syndrome were similar in smokers and nonsmokers in our
study, but the smokers had a significantly greater incidence
of persistent pain on long-term follow-up study. The reason
for this finding is not known.
The work by Opherk et al. (40) suggests that patients
with a chest pain syndrome suggestive of angina pectoris
and abnormal exercise tests have less coronary vascular
reserve than those with atypical chest pain and normal ex-
ercise tests. However, we found no correlation between
coronary vascular reserve and pain characteristics or results
of exercise stress tests in our study.
Interaction between nicotine and the neural control of
the coronary vasculature may explain a decreased coronary
vascular reserve in chronic smokers. Coronary arteries have
both alpha (vasoconstrictor)- and beta, (vasodilator)-adre-
nergic receptors (41,42). These arteries dilate in response
to sympathetic nerve stimulation (41) and to catecholamines
with beta-adrenergic activity (43). The predominant factor
(44) in the response to metabolically induced stimulation is
Figure 2. Coronary vascular reserve In five subjects who smoked about
I pack a day or less and In six subjects who smoked more than I pack a
day for at least 5 years before the study.
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an increase in myocardial contractility mediated by beta,-
receptors, resulting in secondary coronary artery vasodila-
tion with a smaller role mediated by the beta--receptors
(41,45). It has been shown that beta--receptors are not func-
tionally innervated and thus are not involved in neurally
activated responses, in which alpha mediated vasoconstric-
tion predominates (42,44). It is possible that chronic smok-
ing, through the action of nicotine, induces chronic stellate
ganglion stimulation. This would produce a limitation in
the capacity for maximal vasodilation due to chronically
increased alpha tone, unopposed by vasodilator forces. An-
other possibility is that adrenergic receptor sensitivity to
vasodilatory stimuli is altered in chronic smokers.
In conclusion, we have shown that chronic smoking
produces significant changes in one response of the human
coronary circulation. Both the clinical relevance and the
exact mechanism of these changes remain to be elucidated
by further research.
We greatly appreciate the expert assistance of Irma G. Rosenblatt 10 the
preparation of the manuscript. We also acknowledge the technical assis-
tance of William King and Ondina Bobadilla.
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